FEBS Letters
Volume 582, Issue 28 , Pages 3861-3867, 26 November 2008

Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E-115 cells

Edited by Lukas Huber

  • Barbara Bosier

      Affiliations

    • Unité de Chimie Pharmaceutique et de Radiopharmacie (UCL 7340), Université catholique de Louvain, 73 40, Av E.Mounier, B-1200 Brussels, Belgium
  • ,
  • Didier M. Lambert

      Affiliations

    • Unité de Chimie Pharmaceutique et de Radiopharmacie (UCL 7340), Université catholique de Louvain, 73 40, Av E.Mounier, B-1200 Brussels, Belgium
    • D.M. Lambert and E. Hermans contributed equally as senior investigators in this study.
  • ,
  • Emmanuel Hermans

      Affiliations

    • Laboratoire de Pharmacologie expérimentale (UCL 5410), Université catholique de Louvain, 54 10, Av Hippocrate, B-1200 Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Fax: +32 2 764 5460.
    • D.M. Lambert and E. Hermans contributed equally as senior investigators in this study.

Received 1 August 2008; received in revised form 3 October 2008; accepted 15 October 2008. published online 22 October 2008.

Abstract 

Agonists acting at the CB1 cannabinoid receptor in N1E-115 neuroblastoma cells were found to activate MAPK family members with reciprocal efficacies. Thus, HU 210 robustly increased phosphorylation of ERK1/2 whereas CP 55,940 was more effective in activating JNK. The use of selected kinase inhibitors confirmed that distinct signalling cascades were involved in these responses. This reciprocal control of MAPK activity was correlated with the observation that HU 210- and CP 55,940-mediated regulations of tyrosine hydroxylase gene expression were respectively impaired by MEK and JNK inhibitors. These data indicate that complex interactions of the CB1 receptor with intracellular signalling partners controlling MAPK activities may explain the apparent disparities in cellular responses to functional selective agonists.

Keywords: Functional selectivity, Cannabinoid receptor, Tyrosine hydroxylase, MAPK, Drug efficacy, G Protein coupled receptor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0014-5793(08)00839-9

doi:10.1016/j.febslet.2008.10.022

FEBS Letters
Volume 582, Issue 28 , Pages 3861-3867, 26 November 2008